Xavier Pi-Sunyer, MD, MPH and Steven Edelman, MD discuss the differences in A1C reduction when using GLP-1 receptor agonists versus DPP-4 inhibitors. GLP-1 receptor agonists have a larger reduction in A1C…
Xavier Pi-Sunyer, MD, MPH describes how physicians can make the decision between whether to prescribe an injectable GLP-1 agonist treatment or an oral DPP-4 inhibitor when seeking to lower…
Xavier Pi-Sunyer, MD, MPH, discusses incretin therapy, a treatment which increases insulin secretion in type 2 diabetes patients. According to Pi-Sunyer, GLP-1 can be raised in the blood…
Kristen Kulasa, MD, VA San Diego Healthcare System discusses which regimen to pick for patients who come into the hospital that are already on insulin and the guidelines…
Kristen Kulasa, MD, VA San Diego Healthcare System discusses point of care, how often patients should monitor their blood sugar, and how to determine outpatient regimens. Right now…
Kristen Kulasa, MD, VA San Diego Healthcare System talks about the current recommendations for managing patients with diabetes during their time in the hospital. Patients who are admitted…
Kristen Kulasa, MD, VA San Diego Healthcare System, continues with Steven Edelman, MD and discusses the unmet needs in inpatient care. The continuous glucose monitor (CGM) is a new technology…
Jane Jeffrie Seley, DNP, MPH, New York-Presbyterian/Weill Cornell Medical Center, discusses the transition from inpatient to outpatient care in patients with diabetes. When patients return home, diabetes experts…
Jane Jeffrie Seley, DNP, MPH, New York-Presbyterian/Weill Cornell Medical Center talks about follow-up and how to prevent readmissions to the ER. Allowing patients to go in incremental steps with…
Steven Edelman, MD responds to Anne Peters, MD, Director, USC Westside Center for Diabetes, regarding the new type 1 diabetes position statement recently issued. According to Edelman, these statements are…